Researchers from the UBC Faculty of Medicine and Vancouver Coastal Health (VCH) have received $1 million from Canada’s Stem Cell Network to conduct research and a clinical trial for one of the world’s first genetically engineered cell replacement therapies for type 1 diabetes. Continue reading “Dr. David Thompson (Division of Endocrinology) launching clinical trial for first genetically engineered stem cell-based therapy for type 1 diabetes”





